Victory Capital Management Inc. increased its stake in Tesla, Inc. (NASDAQ:TSLA – Free Report) by 4.8% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 2,374,719 shares of the electric vehicle producer’s stock after purchasing an additional 108,055 shares during the quarter. Tesla makes up […]
Penobscot Investment Management Company Inc. raised its position in Marriott International, Inc. (NASDAQ:MAR – Free Report) by 11.0% in the fourth quarter, HoldingsChannel.com reports. The fund owned 4,880 shares of the company’s stock after purchasing an additional 485 shares during the quarter. Penobscot Investment Management Company Inc.’s holdings in Marriott International were worth $1,100,000 as […]
New York Life Investment Management LLC cut its stake in shares of Analog Devices, Inc. (NASDAQ:ADI – Free Report) by 13.3% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 78,213 shares of the semiconductor company’s stock after selling 11,973 shares during the […]
Penobscot Investment Management Company Inc. trimmed its position in CVS Health Co. (NYSE:CVS – Free Report) by 11.0% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 16,032 shares of the pharmacy operator’s stock after selling 1,972 shares during […]
New York Life Investment Management LLC increased its position in Micron Technology, Inc. (NASDAQ:MU – Free Report) by 0.8% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 172,260 shares of the semiconductor manufacturer’s stock after buying an additional 1,310 […]
New York Life Investment Management LLC decreased its position in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 12.2% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 196,816 shares of the biopharmaceutical company’s stock after selling 27,356 shares during the […]
Victory Capital Management Inc. boosted its holdings in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 7.7% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 2,489,705 shares of the biopharmaceutical company’s stock after purchasing an additional 178,536 shares during the quarter. […]
Victory Capital Management Inc. lifted its position in shares of Xcel Energy Inc. (NASDAQ:XEL – Free Report) by 3.5% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 7,766,048 shares of the company’s stock after acquiring an additional 261,426 shares during […]
Total Investment Management Inc. bought a new stake in shares of Alphabet Inc. (NASDAQ:GOOG – Free Report) during the 4th quarter, according to its most recent filing with the SEC. The firm bought 1,766 shares of the information services provider’s stock, valued at approximately $249,000. Several other hedge funds and other institutional investors have also […]
Victory Capital Management Inc. cut its stake in Comcast Co. (NASDAQ:CMCSA – Free Report) by 10.2% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 6,040,145 shares of the cable giant’s stock after selling 683,591 shares during the period. Victory Capital […]
Stevens Capital Management LP bought a new position in shares of Hologic, Inc. (NASDAQ:HOLX – Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 11,283 shares of the medical equipment provider’s stock, valued at approximately $806,000. A number […]
Syon Capital LLC boosted its position in shares of Pfizer Inc. (NYSE:PFE – Free Report) by 111.4% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 64,444 shares of the biopharmaceutical company’s stock after purchasing an additional 33,961 shares during […]